It activates both GLP-1 and GIP receptors, which is one reason it tends to produce larger weight reductions than semaglutide
Colorado has the option to stay the current course, which offers more familiarity and less disruption or adopt a full managed care model, which would be riskier but may or may not bring greater savings and more budgetary certainty in the long run
Marketing of brand Byetta has been discontinued in the United States
Anesthetic agents interact indirectly through aspiration risk
This process mimics the natural tanning response that occurs when the skin is exposed to UV radiation but without the need for extensive sun exposure
[3] For individuals with obesity, GLP-1 agonists can offer more than just a reduction in body weight they can also help to lower blood pressure, improve cholesterol levels, and reduce the risk of cardiovascular disease